<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>aggregate-data on nlmixr2</title>
    <link>https://blog.nlmixr2.org/tags/aggregate-data/</link>
    <description>Recent content in aggregate-data on nlmixr2</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en</language>
    <lastBuildDate>Thu, 02 Jul 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://blog.nlmixr2.org/tags/aggregate-data/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Fitting PK/PD models to published data with admixr2</title>
      <link>https://blog.nlmixr2.org/blog/2026-07-02-admixr2-mbma/</link>
      <pubDate>Thu, 02 Jul 2026 00:00:00 +0000</pubDate>
      
      <guid>https://blog.nlmixr2.org/blog/2026-07-02-admixr2-mbma/</guid>
      <description>Usually, pharmacometric modelling starts with a dataset with individual patient data: one row per observation, in a software-ready format. To model these data, you would first need to get access to the data, which means data-sharing agreements, trial access, or in-house studies. This process is often slow or even not possible due to privacy or competition. However, researchers do publish their model and sometimes summary metrics.
The published reports do contain useful information.</description>
    </item>
    
  </channel>
</rss>
